Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT05884905
Eligibility Criteria:
Inclusion Criteria:
* Cancer patient who has plan to receive first cycle of cisplatin \>= 60 mg/m2
* Normal serum creatinine and creatinine clearance \>= 50 ml/min
* Age \< 75 years old
* Serum albumin \>= 3 g/dl
* Plan to receive optimal antiemetic regimen consisting of olanzapine or neurokinase 1 receptor antagonist
Exclusion Criteria:
* The patient who receives other chemotherapy with adminstration volume higher than 500 ml
* Prior heart failure or known left ventricular ejection fraction \> 50%
* Prior renal dysfunction within 3 months
* Uncontrolled renal disease
* current use of diuretic or non-steroidal anti-inflammatory drug (NSAIDs) or starting angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blockade (ARB) within 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05884905
Study Brief:
Protocol Section:
NCT05884905